tiprankstipranks
Advertisement
Advertisement

AU:MSB Stock Latest News

Largest borrow rate increases among liquid names
The FlyLargest borrow rate increases among liquid names
6d ago
NVS
PEW
Mesoblast Earnings Call: Ryoncil Momentum, Pipeline Upside
PremiumCompany Announcements
Mesoblast Earnings Call: Ryoncil Momentum, Pipeline Upside
10d ago
Mesoblast CEO Granted Additional Options Following Shareholder Approval
PremiumCompany Announcements
Mesoblast CEO Granted Additional Options Following Shareholder Approval
16d ago
Mesoblast Issues 3.25 Million Unquoted Options Under Employee Incentive Scheme
PremiumCompany Announcements
Mesoblast Issues 3.25 Million Unquoted Options Under Employee Incentive Scheme
16d ago
Mesoblast Sets Inaugural R&D Day to Showcase Strategy, Ryoncil and Pipeline
PremiumCompany Announcements
Mesoblast Sets Inaugural R&D Day to Showcase Strategy, Ryoncil and Pipeline
19d ago
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
24d ago
KDK
MPT
Mesoblast hires Regeneron veteran to lead clinical development and medical affairs
Premium
Company Announcements
Mesoblast hires Regeneron veteran to lead clinical development and medical affairs
25d ago
Mesoblast Director Gregory George Deepens Stake with US$16.4m Share Purchases
Premium
Company Announcements
Mesoblast Director Gregory George Deepens Stake with US$16.4m Share Purchases
27d ago
Mesoblast Rides Ryoncil Launch to Revenue Surge and Advances Late-Stage Cell Therapy Pipeline
PremiumCompany Announcements
Mesoblast Rides Ryoncil Launch to Revenue Surge and Advances Late-Stage Cell Therapy Pipeline
1M ago
Mesoblast Updates Investors on 2025 Results and Operational Outlook
PremiumCompany Announcements
Mesoblast Updates Investors on 2025 Results and Operational Outlook
1M ago
Mesoblast Files Form 6-K Providing Interim Financial and Risk Disclosures
PremiumCompany Announcements
Mesoblast Files Form 6-K Providing Interim Financial and Risk Disclosures
1M ago
Mesoblast to Present Half-Year Results as It Expands Global Cell Therapy Portfolio
PremiumCompany Announcements
Mesoblast to Present Half-Year Results as It Expands Global Cell Therapy Portfolio
1M ago
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
2M ago
GDS
MMM
Mesoblast’s Ryoncil Shows Strong Early Survival in Real-World Use as U.S. Rollout Expands
Premium
Company Announcements
Mesoblast’s Ryoncil Shows Strong Early Survival in Real-World Use as U.S. Rollout Expands
2M ago
JPMorgan Ceases to Be Substantial Holder in Mesoblast
Premium
Company Announcements
JPMorgan Ceases to Be Substantial Holder in Mesoblast
2M ago
Mesoblast received FDA feedback on potential BLA for rexlemestrocel-L
PremiumThe Fly
Mesoblast received FDA feedback on potential BLA for rexlemestrocel-L
3M ago
MESO
FDA Feedback Boosts Mesoblast’s Rexlemestrocel‑L Bid in Chronic Low Back Pain
PremiumCompany Announcements
FDA Feedback Boosts Mesoblast’s Rexlemestrocel‑L Bid in Chronic Low Back Pain
3M ago
Mesoblast Issues 6.9 Million New Shares Following Conversion of Unquoted Securities
PremiumCompany Announcements
Mesoblast Issues 6.9 Million New Shares Following Conversion of Unquoted Securities
3M ago
Mesoblast Seeks ASX Quotation for 7.3 Million New Shares from Employee Scheme
PremiumCompany Announcements
Mesoblast Seeks ASX Quotation for 7.3 Million New Shares from Employee Scheme
3M ago
Mesoblast Director Eric Rose Increases Shareholding Through Option Exercise
PremiumCompany AnnouncementsMesoblast Director Eric Rose Increases Shareholding Through Option Exercise
3M ago
Mesoblast Director Lyn Cobley Increases On-Market Shareholding
Premium
Company Announcements
Mesoblast Director Lyn Cobley Increases On-Market Shareholding
3M ago
Mesoblast Boosts Ryoncil Sales 60% and Secures Cheaper US$125m Financing
Premium
Company Announcements
Mesoblast Boosts Ryoncil Sales 60% and Secures Cheaper US$125m Financing
3M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >